Page last updated: 2024-09-04

technetium tc 99m citrate and technetium tc 99m medronate

technetium tc 99m citrate has been researched along with technetium tc 99m medronate in 3 studies

Compound Research Comparison

Studies (technetium tc 99m citrate)	Trials (technetium tc 99m citrate)	Recent Studies (post-2010) (technetium tc 99m citrate)	Studies (technetium tc 99m medronate)	Trials (technetium tc 99m medronate)	Recent Studies (post-2010) (technetium tc 99m medronate)
19	1	0	4,609	181	549

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aras, T; Bekdik, CF; Cağlar, M; Ercan, MT; Tokgözoğlu, AM	1
Bhatnagar, A; Chakravarty, KL; Chopra, MK; Kashyap, R; Mishra, P; Mondal, A; Rawat, HS; Sharma, R	1
Bhatnagar, A; Chakravarty, K; Chopra, MK; Chuttani, K; Gupta, A; Jain, CM; Mishra, P; Mondal, A; Sharma, R	1

Trials

1 trial(s) available for technetium tc 99m citrate and technetium tc 99m medronate

Article	Year
99Tcm-citrate: a new bone imaging radiopharmaceutical. Nuclear medicine communications, 1999, Volume: 20, Issue:11 Topics: Adult; Bone and Bones; Bone Diseases; Bone Neoplasms; Citrates; Drug Stability; Female; Humans; Hydrogen-Ion Concentration; Male; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Technetium Compounds; Technetium Tc 99m Medronate; Tin Compounds; Tissue Distribution	1999

Article

Year

99Tcm-citrate: a new bone imaging radiopharmaceutical.

Nuclear medicine communications, 1999, Volume: 20, Issue:11

Topics: Adult; Bone and Bones; Bone Diseases; Bone Neoplasms; Citrates; Drug Stability; Female; Humans; Hydrogen-Ion Concentration; Male; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Technetium Compounds; Technetium Tc 99m Medronate; Tin Compounds; Tissue Distribution

1999

Other Studies

2 other study(ies) available for technetium tc 99m citrate and technetium tc 99m medronate

Article	Year
The value of Tc-99m citrate scintigraphy in chronic osteomyelitis. An indicator of the involved bone. Clinical nuclear medicine, 1995, Volume: 20, Issue:8 Topics: Adult; Bone and Bones; Citrates; Female; Humans; Male; Middle Aged; Organotechnetium Compounds; Osteomyelitis; Radionuclide Imaging; Technetium Tc 99m Medronate	1995
Differentiation of malignant and degenerative benign bone disease using Tc-99m MDP and Tc-99m citrate scintigraphy. Clinical nuclear medicine, 1998, Volume: 23, Issue:11 Topics: Adult; Bone Diseases; Bone Neoplasms; Case-Control Studies; Citrates; Diagnosis, Differential; Female; Humans; Male; Middle Aged; Organotechnetium Compounds; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Medronate; Time Factors	1998

Article

Year

The value of Tc-99m citrate scintigraphy in chronic osteomyelitis. An indicator of the involved bone.

Clinical nuclear medicine, 1995, Volume: 20, Issue:8

Topics: Adult; Bone and Bones; Citrates; Female; Humans; Male; Middle Aged; Organotechnetium Compounds; Osteomyelitis; Radionuclide Imaging; Technetium Tc 99m Medronate

1995

Differentiation of malignant and degenerative benign bone disease using Tc-99m MDP and Tc-99m citrate scintigraphy.

Clinical nuclear medicine, 1998, Volume: 23, Issue:11

Topics: Adult; Bone Diseases; Bone Neoplasms; Case-Control Studies; Citrates; Diagnosis, Differential; Female; Humans; Male; Middle Aged; Organotechnetium Compounds; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Medronate; Time Factors

1998